James E. Flynn 13D/13G Filings for Foghorn Therapeutics Inc. (FHTX)

James E. Flynn 13D and 13G filings for Foghorn Therapeutics Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-09-20
6:00 pm
Purchase
2024-09-1313GFoghorn Therapeutics Inc.
FHTX
James E. Flynn2,935,295
5.310%
2,935,295increase
(New Position)
Filing